Summary by Futu AI
SeaStar Medical Holding Corporation, a medical technology company, has announced a registered direct offering of 947,868 shares of its common stock at a price of $10.55 per share. The offering is accompanied by a concurrent private placement of unregistered common stock purchase warrants, exercisable at $10.55, immediately upon issuance and expiring five years from the date of issuance. The purchase price for each share of common stock is also set at $10.55. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about July 11, 2024, subject to customary closing conditions. The proceeds, before expenses, are estimated to be approximately $9.3 million and are intended for the redemption and repayment of certain notes, as well as funding the company's development and commercialization activities and general corporate purposes. This offering follows SeaStar Medical's recent compliance with Nasdaq's minimum market value requirement and its ongoing efforts to maintain its listing on the exchange.